Pharmaceutical

NICE recommends Lilly’s tirzepatide to treat T2D

The UK NICE has recommended Eli Lilly’s tirzepatide for the treatment of adult patients with inadequately controlled type 2 diabetes.

Sep 9, 2023 - 20:00
NICE recommends Lilly’s tirzepatide to treat T2D
The UK NICE has recommended Eli Lilly’s tirzepatide for the treatment of adult patients with inadequately controlled type 2 diabetes.
Read the original article

Tags:

Previous Article

Otsuka and ShapeTX to develop gene therapies for eye diseases

Next Article

EC expands indication approval for Merck’s Ebola vaccine

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

FDA chastens pet companies over antibiotics

FDA chastens pet companies over antibiotics

Dec 15, 2023

STAT+: Lawmakers circle parents’ rights in gender-affirming care hearing

STAT+: Lawmakers circle parents’ rights in gender-affir...

Jul 30, 2023

Silence announces $120m private placement for depositary shares

Silence announces $120m private placement for depositar...

Feb 6, 2024